Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…

Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy explores the innovative use of molecularly imprinted polymers (MIPs) in developing targeted drug delivery systems for cancer types such as breast, prostate, and lung. This comprehensive guide highlights how molecular imprinting techniques can enhance treatment specificity, reduce systemic toxicity, and improve therapeutic outcomes, addressing the critical need for precision medicine in oncology. Organized with detailed chapters, flowcharts, and case studies, it provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to advance cancer therapies through cutting-edge drug delivery technologies.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Stock availability can be subject to change without notice. We recommend calling the shop or contacting our online team to check availability of low stock items. Please see our Shopping Online page for more details.
Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy explores the innovative use of molecularly imprinted polymers (MIPs) in developing targeted drug delivery systems for cancer types such as breast, prostate, and lung. This comprehensive guide highlights how molecular imprinting techniques can enhance treatment specificity, reduce systemic toxicity, and improve therapeutic outcomes, addressing the critical need for precision medicine in oncology. Organized with detailed chapters, flowcharts, and case studies, it provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to advance cancer therapies through cutting-edge drug delivery technologies.